Monoclonal Antibody Treatment

St. Luke’s Now Offering Monoclonal Antibody Treatment for Eligible Patients with COVID-19

The Treatment is Found to Have Reduced COVID-19 Hospitilizations

DULUTH, Minn. – St. Luke’s in Duluth is now offering an emergency use COVID-19 antibody treatment that medical experts say has been proven to reduce the length of hospitalizations. The monoclonal antibody treatment is produced in a lab. The antibodies work to attack the COVID-19 virus in the patient’s system. St. Luke’s Infectious Disease Specialist, Dr. Andrew Thompson, says the…